MACROGENICS INC — Director's Dealing 2026

Feb 18, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2026-02-12

Reporting Person: Spitznagel Thomas (Sr VP, Technical Ops)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-15	Common Stock	M	13332	—	Acquired	44063	Direct
2026-02-15	Common Stock	F	5520	$1.71	Disposed	38543	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-15	Restricted Stock Unit	$	M	13332	Disposed		Common Stock (13332)	Direct
2026-02-12	Restricted Stock Unit	$	A	25000	Acquired		Common Stock (25000)	Direct
2026-02-12	Employee Stock Option (right to buy)	$1.71	A	150000	Acquired	2036-02-12	Common Stock (150000)	Direct

Footnotes

F1: On February 15, 2023, the reporting person was granted 40,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis.

F2: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

F3: 12.5% of the shares underlying the grant became exercisable one year after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.